Kaiser Health News covers health care in the Midwest, with a bureau headquartered in St. Louis and staff reporters based in Iowa, Minnesota, and South Dakota.

KHN’s ‘What the Health?’: Kansas Makes a Statement

In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.

Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave

As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.

Patients With Epilepsy Navigate Murky Unregulated CBD Industry

The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.